In the past week, BIOR stock has gone down by -14.95%, with a monthly decline of -49.62% and a quarterly plunge of -38.44%. The volatility ratio for the week is 9.40%, and the volatility levels for the last 30 days are 7.93% for Biora Therapeutics Inc The simple moving average for the past 20 days is -31.34% for BIOR’s stock, with a -68.37% simple moving average for the past 200 days.
Is It Worth Investing in Biora Therapeutics Inc (NASDAQ: BIOR) Right Now?
BIOR has 36-month beta value of 1.24. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BIOR is 32.31M, and currently, short sellers hold a 4.15% ratio of that float. The average trading volume of BIOR on April 19, 2024 was 458.31K shares.
BIOR) stock’s latest price update
Biora Therapeutics Inc (NASDAQ: BIOR) has experienced a decline in its stock price by -6.63 compared to its previous closing price of 0.64. However, the company has seen a fall of -14.95% in its stock price over the last five trading days. Seeking Alpha reported 2024-03-26 that Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript
BIOR Trading at -38.65% from the 50-Day Moving Average
After a stumble in the market that brought BIOR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.05% of loss for the given period.
Volatility was left at 7.93%, however, over the last 30 days, the volatility rate increased by 9.40%, as shares sank -50.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.84% lower at present.
During the last 5 trading sessions, BIOR fell by -14.95%, which changed the moving average for the period of 200-days by -84.27% in comparison to the 20-day moving average, which settled at $0.8427. In addition, Biora Therapeutics Inc saw -55.59% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIOR
Current profitability levels for the company are sitting at:
- -16785.75 for the present operating margin
- -137.75 for the gross margin
The net margin for Biora Therapeutics Inc stands at -32173.0. The total capital return value is set at 2.11.
Based on Biora Therapeutics Inc (BIOR), the company’s capital structure generated -0.85 points at debt to capital in total, while cash flow to debt ratio is standing at -1.04. The debt to equity ratio resting at -0.46. The interest coverage ratio of the stock is -14.5.
Currently, EBITDA for the company is -66.59 million with net debt to EBITDA at -0.48. When we switch over and look at the enterprise to sales, we see a ratio of 13431.83. The receivables turnover for the company is 0.0for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.30.
Conclusion
To put it simply, Biora Therapeutics Inc (BIOR) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
